Talk:MHC class II

	This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology articles
???	This article has not yet received a rating on the importance scale.
	This article is supported by the Genetics task force (assessed as Mid-importance).
	This article is supported by the Molecular and Cell Biology task force (assessed as Mid-importance).

Untitled

"MHC (major histocompatibility complex) Class II molecules are found only on a two specialized cell types, including macrophages, dendritic cells and B cells, all of which are professional antigen-presenting cells (APCs)."

I suggest to remove "only on two". Is it really found only on two cell types (since three are mentionned)? Also, MHC class II could be found on endothelial cells in the Central Nervous System (CNS) (see: Witwer KW et al, PLoS ONE 4(12):e8129, 2009, doi:10.1371/journal.pone.0008129). --Corpshumain (talk) 17:09, 11 March 2010 (UTC)[reply]

Wiki Education Foundation-supported course assignment

This article is or was the subject of a Wiki Education Foundation-supported course assignment. Further details are available on the course page. Student editor(s): Immcarle62.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 03:02, 17 January 2022 (UTC)[reply]

destruction of part of a cell or eliminating a gene from the secence of a cell.

can you eliminate gene secence without changing the function of a cell. Example MHC class 11 can it be eliminated from the cellular make up of the T cell without changing the function of the cell? my understanding is that a few structures of the T cell is really not needed in opinion it does more harm than good like the kinisos process it changes the cell intarally. could this change awaken dormined cancerious cells etc. —Preceding unsigned comment added by Taylor's theory (talk • contribs) 11:38, 4 July 2010 (UTC)[reply]

External links modified

Hello fellow Wikipedians,

I have just modified one external link on MHC class II. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:

Added archive https://web.archive.org/web/20081226224824/http://www.cehs.siu.edu/fix/medmicro/mhc.htm to http://www.cehs.siu.edu/fix/medmicro/mhc.htm

When you have finished reviewing my changes, you may follow the instructions on the template below to fix any issues with the URLs.

This message was posted before February 2018. After February 2018, "External links modified" talk page sections are no longer generated or monitored by InternetArchiveBot. No special action is required regarding these talk page notices, other than regular verification using the archive tool instructions below. Editors have permission to delete these "External links modified" talk page sections if they want to de-clutter talk pages, but see the RfC before doing mass systematic removals. This message is updated dynamically through the template {{source check}} (last update: 5 June 2024).

If you have discovered URLs which were erroneously considered dead by the bot, you can report them with this tool.
If you found an error with any archives or the URLs themselves, you can fix them with this tool.

Cheers.—InternetArchiveBot (Report bug) 16:04, 10 January 2018 (UTC)[reply]

Addition of a section on MHC II deficiency

Bibliography: Roifman, C., & Grunebaum, E. (n.d.). Primary T-cell Immunodeficiencies . In Clinical Immunology (4th ed., pp. 437-453). doi:https://doi.org/10.1016/B978-0-7234-3691-1.00052-0

Delves, P. J., & Roitt, I. M. (1998). Encyclopedia of immunology. London: Academic Press.

Mak, T. W., & Saunders, M. E. (2006). The immune response: basic and clinical principles ;. Amsterdam: Elsevier Acad. Press.

Advances in Immunology (Vol. 136). (2016). Academic Pr.

Steimle, V., Otten, L., Zufferey, M., & Mach, B. (n.d.). Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). In Cell (1st ed., Vol. 75, pp. 135-146). doi:https://doi.org/10.1016/S0092-8674(05)80090-X

Immcarle62 (talk) 02:05, 29 January 2018 (UTC) Immcarle62[reply]